Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2007-12-18
pubmed:abstractText
Proliferative benign breast conditions are associated with elevated risk of breast cancer, whereas nonproliferative conditions are not strongly associated with risk. Factors acting before onset of hyperplasia might be associated with both benign conditions and breast cancer, whereas those on the proliferative disease-to-cancer pathway would be associated only with cancer. Soy isoflavone exposure may influence breast cancer risk, but little is known of its association with benign conditions.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1055-9965
pubmed:author
pubmed:issnType
Print
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2579-86
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Plasma isoflavones and fibrocystic breast conditions and breast cancer among women in Shanghai, China.
pubmed:affiliation
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. jlampe@fhcrc.org
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural